Human papillomavirus vaccines. WHO position paper

Wkly Epidemiol Rec. 2009 Apr 10;84(15):118-31.
[Article in En, French]
No abstract available

MeSH terms

  • Condylomata Acuminata / prevention & control
  • Cost-Benefit Analysis
  • Female
  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Humans
  • Male
  • Papillomaviridae / immunology
  • Papillomavirus Infections / economics
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / prevention & control
  • Papillomavirus Vaccines / administration & dosage
  • Papillomavirus Vaccines / economics
  • Papillomavirus Vaccines / immunology
  • Papillomavirus Vaccines / therapeutic use*
  • World Health Organization*

Substances

  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Papillomavirus Vaccines